Gene therapy shot may ease diabetic nerve pain
NCT ID NCT01002235
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase trial tested a gene therapy called Engensis (VM202) in 12 people with painful diabetic peripheral neuropathy. Participants received injections into their calf muscles to see if it was safe and could reduce pain. The study focused on safety and pain scores over 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Engensis (VM202), a gene therapy given as injections into the calf muscle
- What this could lead to
- If it works, this could point toward a new way to ease nerve pain in people with diabetes.
- What could go wrong
- This is a very small, early-phase trial with only 12 people, so results may not apply widely. The main goal is safety, not proof of effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAINFUL DIABETIC PERIPHERAL NEUROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Diablo Clinical Research Hospital
Walnut Creek, California, 94598, United States
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a kitchen spice soothe diabetic nerve pain?
- Ultrasound-Enhanced gel and nerve stretching may ease diabetic foot pain
- Ear stimulation device shows promise for diabetic nerve pain
- Spinal zap may soothe diabetic leg pain and boost circulation
- New pill could ease diabetic nerve pain
- New hope for diabetic nerve pain? drug tested in 61 patients